BETHANY COLLINS: Open Payments
NPI 1346339066 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$383 in 21 payments from 8 companies in 2025. Trend: 2023 $860 · 2024 $619 · 2025 $383
Food & beverage: $383
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $154 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $53 |
| ABBVIE INC. | 3 | $49 |
| Alkermes, Inc. | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: CAPLYTA, XIFAXAN, VRAYLAR, ARISTADA, ABILIFY ASIMTUFII, SPRAVATO, Auvelity, INGREZZA.
Industry payments across AR — which companies pay providers there.
